NSF Seeks Data to Fill Ozone Hole

WASHINGTON—There’s a time for research and a time for panic. Despite what you already may have read about the reduced levels of ozone in Antarctica, NSF officials say that insufficient data pose a greater threat to scientists than ultraviolet rays. “Antarctica is a naturally occurring laboratory to get a good research program going,” said Peter Wilkniss, director of the Division of Polar Programs at NSF. “And we need to understand better what goes on down there.

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—There’s a time for research and a time for panic. Despite what you already may have read about the reduced levels of ozone in Antarctica, NSF officials say that insufficient data pose a greater threat to scientists than ultraviolet rays.

“Antarctica is a naturally occurring laboratory to get a good research program going,” said Peter Wilkniss, director of the Division of Polar Programs at NSF. “And we need to understand better what goes on down there.”

Scary headlines appeared the day after Wilkniss and others told Congress that ozone depletion had reached record levels in September. The new information, witnesses were quoted as saying, raised concern about the health of scientists who might be exposed to the harmful rays as they conducted experiments at the South Pole.

But the truth, as always, is a bit more complicated. Once NSF officials suspected that the ozone hole was deepening, they asked a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies